Reports

Ideas That Generate Results

Global Influenza Vaccine Market Outlook 2022

Global Influenza Vaccine Market Outlook 2022

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jun, 2016| No. of Pages : 95

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 2100.00
CD-ROM Mail Delivery
US$ 2200.00
Hard Copy Mail Delivery
US$ 2200.00
Electronic Access - Multi-User License
US$ 3000.00
1. Analyst View

2. Research Methodology

3. Influenza Vaccine - Introduction

4. Industry Trends and Drivers
     4.1 Increasing Pandemic Outbreak
     4.2 Rising Affordability
     4.3 Rising Ageing Population
     4.4 Development of Universal Flu Vaccine
     4.5 Collaborations in the Market

5. Industry Challenges
     5.1 Testing and Regulatory Issues
     5.2 Low Awareness
     5.3 Lack of Medical and Healthcare Infrastructure

6. Global Influenza Vaccine Market Outlook 2022
     6.1 Current Market Overview and Future Outlook
     6.2 Major Marketed Vaccines
            6.2.1 Fluzone/Vaxigrip
            6.2.2 FluMist
            6.2.3 Fluarix and Flulaval
            6.2.4 Anflu
            6.2.5 Fluvax/Afluria
            6.2.6 Flucelvax and Fluvirin

7. Key Geographical Market
     7.1 Americas
     7.2 Europe
     7.3 Asia Pacific
            7.3.1 China
            7.3.2 India
            7.3.3 Australia
            7.3.4 Japan
    7.4 Rest of the World

8. Global Influenza Vaccine Market: Pipeline Analysis

9. Global Influenza Vaccine Market: Pricing Analysis

10. Competitive Assessment
       10.1 Sanofi
                10.1.1 Business Description
                10.1.2 Financial Overview
                10.1.3 Influenza Vaccine Business
       10.2 GlaxoSmithKline Plc (GSK)
                10.2.1 Business Overview
                10.2.2 Financial Overview
                10.2.3 Influenza Vaccine Business
       10.3 CSL Ltd.
                10.3.1 Business Overview
                10.3.2 Financial Overview
                10.3.3 Influenza Vaccine Business
       10.4 AstraZeneca Plc
                10.4.1 Business Overview
                10.4.2 Financial Overview
                10.4.3 Influenza Vaccine Business
       10.5 Sinovac Biotech
                10.5.1 Business Overview
                10.5.2 Financial Overview
                10.5.3 Influenza Vaccine Business
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.